These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19724024

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition.
    Kang BY, Khan JA, Ryu S, Shekhar R, Seung KB, Mehta JL.
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):417-24. PubMed ID: 20422739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cross-talk between inflammation and angiotensin II: studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA.
    Wang X, Khaidakov M, Ding Z, Mitra S, Lu J, Liu S, Mehta JL.
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1394-401. PubMed ID: 23354398
    [Abstract] [Full Text] [Related]

  • 7. LOX-1 dependent overexpression of immunoglobulins in cardiomyocytes in response to angiotensin II.
    Kang BY, Hu C, Prayaga S, Khaidakov M, Sawamura T, Seung KB, Mehta JL.
    Biochem Biophys Res Commun; 2009 Feb 06; 379(2):395-9. PubMed ID: 19126408
    [Abstract] [Full Text] [Related]

  • 8. Rosuvastatin inhibits norepinephrine-induced cardiac hypertrophy via suppression of Gh.
    Choi EY, Chang W, Lim S, Song BW, Cha MJ, Kim HJ, Choi E, Jang Y, Chung N, Hwang KC.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):56-62. PubMed ID: 19883640
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni M, Lembo G, Volpe M.
    Am J Hypertens; 2005 Apr 10; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [Abstract] [Full Text] [Related]

  • 10. Rosuvastatin attenuates atherosclerosis in rats via activation of scavenger receptor class B type I.
    Li Y, Wang Q, Zhou J, Xu Q, Chu X, Sun T, Liu X, Cai S.
    Eur J Pharmacol; 2014 Jan 15; 723():23-8. PubMed ID: 24333476
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1.
    Li D, Chen H, Romeo F, Sawamura T, Saldeen T, Mehta JL.
    J Pharmacol Exp Ther; 2002 Aug 15; 302(2):601-5. PubMed ID: 12130721
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
    Kim YS, Ahn Y, Hong MH, Kim KH, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, Kang JC.
    J Cardiovasc Pharmacol; 2007 Jun 15; 49(6):376-83. PubMed ID: 17577102
    [Abstract] [Full Text] [Related]

  • 16. Synergism of simvastatin with losartan prevents angiotensin II-induced cardiomyocyte apoptosis in vitro.
    Xu J, Lü XW, Huang Y, Zhu PL, Li J.
    J Pharm Pharmacol; 2009 Apr 15; 61(4):503-10. PubMed ID: 19298698
    [Abstract] [Full Text] [Related]

  • 17. Aspirin downregulates angiotensin type 1 receptor transcription implications in capillary formation from endothelial cells.
    Mitra S, Wang X, Khaidakov M, Ding Z, Ayyadevera S, Hearnsberger E, Goyal T, Mehta JL.
    J Cardiovasc Pharmacol; 2012 Aug 15; 60(2):187-92. PubMed ID: 22561363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiotensin-II and rosuvastatin influence matrix remodeling in human mesangial cells via metalloproteinase modulation.
    Solini A, Rossi C, Santini E, Madec S, Salvati A, Ferrannini E.
    J Hypertens; 2011 Oct 15; 29(10):1930-9. PubMed ID: 21881526
    [Abstract] [Full Text] [Related]

  • 20. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.
    Chen J, Li D, Schaefer R, Mehta JL.
    Atherosclerosis; 2006 Feb 15; 184(2):295-301. PubMed ID: 16005008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.